Loading company filing…
Find a company. Follow its revenue through costs and profit.
Coverage includes separate ticker and security records; counts are not unique companies.
Sankey diagram of Veeva Systems Inc. A complete text table follows the diagram.
R&D and quality systems now exceed the commercial CRM and data franchise, while subscriptions remain the economic core of both
Swipe to explore
Every flow is an exact reported product-area and revenue-model amount. The editorial selection maps Veeva across the life-sciences product lifecycle and distinguishes recurring cloud subscriptions from services; no allocation was modeled.
Labels and narrative explain the filing. A category marked “arithmetic bridge” or “residual” is calculated from reported totals, rather than a separately reported line.
| Category | Stage | Value | Notes |
|---|---|---|---|
| Commercial Solutions | 1 | $395M | CRM, engagement and commercial data |
| R&D & Quality Solutions | 1 | $488M | Clinical, regulatory, safety and manufacturing |
| Cloud & data subscriptions | 2 | $730M | 83% of total revenue |
| Implementation & consulting | 2 | $153M | 17% of total revenue |
| From | To | Value |
|---|---|---|
| Commercial Solutions | Cloud & data subscriptions | $338M |
| Commercial Solutions | Implementation & consulting | $57.6M |
| R&D & Quality Solutions | Cloud & data subscriptions | $392M |
| R&D & Quality Solutions | Implementation & consulting | $95.2M |